Coeliac disease

The Lancet

Volumn 391, Issue 10115, 2018, Pages 70-81

  Lebwohl, Benjamin ^a,b   Sanders, David S ^c   Green, Peter H R ^a  

^a New York Presbyterian Columbia University Medical Center   (United States)

^b Department of Medicine   (United States)

^c ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOMYSIUM ANTIBODY; GLUTEN; HLA DQ2 ANTIGEN; HLA DQ8 ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; LARAZOTIDE; LATIGLUTENASE; PLACEBO; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; T LYMPHOCYTE RECEPTOR;

BIFIDOBACTERIUM BIFIDUM; BREAST FEEDING; CASE FINDING; CELIAC DISEASE; CHRONIC DIARRHEA; COLORECTAL CANCER; DIETARY COMPLIANCE; DUODENUM BIOPSY; GASTROINTESTINAL INFECTION; GENETIC RISK; GLUTEN FREE DIET; HLA TYPING; HUMAN; IMMUNOGLOBULIN A DEFICIENCY; INFANT FEEDING; INTESTINE FLORA; INTESTINE VILLUS ATROPHY; MALABSORPTION; MORTALITY RISK; OSTEOPOROSIS; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; T CELL LYMPHOMA;

CELIAC DISEASE; HUMANS;

EID: 85026478725     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(17)31796-8     Document Type: Review

References (144)

1. Green, PH, Jabri, B, Coeliac disease. Lancet 362 (2003), 383–391.
2. Di Sabatino, A, Corazza, GR, Coeliac disease. Lancet 373 (2009), 1480–1493.
3. Shan, L, Molberg, Ø, Parrot, I, et al. Structural basis for gluten intolerance in celiac sprue. Science 297 (2002), 2275–2279.
4. Matysiak-Budnik, T, Moura, IC, Arcos-Fajardo, M, et al. Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease. J Exp Med 205 (2008), 143–154.
5. Visser, J, Rozing, J, Sapone, A, Lammers, K, Fasano, A, Tight junctions, intestinal permeability, and autoimmunity: celiac disease and type 1 diabetes paradigms. Ann N Y Acad Sci 1165 (2009), 195–205.
6. Schumann, M, Siegmund, B, Schulzke, JD, Fromm, M, Celiac disease: role of the epithelial barrier. Cell Mol Gastroenterol Hepatol 3 (2017), 150–162.
7. Dieterich, W, Ehnis, T, Bauer, M, et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 3 (1997), 797–801.
8. Molberg, O, Mcadam, SN, Körner, R, et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 4 (1998), 713–717.
9. Lundin, KE, Scott, H, Hansen, T, et al. Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med 178 (1993), 187–196.
10. Taylor, TB, Schmidt, LA, Meyer, LJ, Zone, JJ, Transglutaminase 3 present in the IgA aggregates in dermatitis herpetiformis skin is enzymatically active and binds soluble fibrinogen. J Invest Dermatol 135 (2015), 623–625.
11. Hadjivassiliou, M, Aeschlimann, P, Sanders, DS, et al. Transglutaminase 6 antibodies in the diagnosis of gluten ataxia. Neurology 80 (2013), 1740–1745.
12. Abadie, V, Discepolo, V, Jabri, B, Intraepithelial lymphocytes in celiac disease immunopathology. Semin Immunopathol 34 (2012), 551–566.
13. Abadie, V, Jabri, B, IL-15: a central regulator of celiac disease immunopathology. Immunol Rev 260 (2014), 221–234.
14. Huebener, S, Tanaka, CK, Uhde, M, et al. Specific nongluten proteins of wheat are novel target antigens in celiac disease humoral response. J Proteome Res 14 (2015), 503–511.
15. Junker, Y, Zeissig, S, Kim, SJ, et al. Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll-like receptor 4. J Exp Med 209 (2012), 2395–2408.
16. Gasbarrini, G, Mangiola, F, Wheat-related disorders: a broad spectrum of ‘evolving’ diseases. United European Gastroenterol J 2 (2014), 254–262.
17. Kuja-Halkola, R, Lebwohl, B, Halfvarson, J, Wijmenga, C, Magnusson, PK, Ludvigsson, JF, Heritability of non-HLA genetics in coeliac disease: a population-based study in 107 000 twins. Gut 65 (2016), 1793–1798.
18. Fasano, A, Berti, I, Gerarduzzi, T, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 163 (2003), 286–292.
19. Karell, K, Louka, AS, Moodie, SJ, et al. HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease. Hum Immunol 64 (2003), 469–477.
20. Taylor, AK, Lebwohl, B, Snyder, CL, et al. Celiac disease. Pagon, RA, Adam, MP, Ardinger, HH, et al. (eds.) GeneReviews, 2015, University of Washington, Seattle.
21. Liu, E, Dong, F, Barón, AE, et al. High incidence of celiac disease in a long-term study of adolescents with susceptibility genotypes. Gastroenterology 152 (2017), 1329–1336.
22. Gutierrez-Achury, J, Zhernakova, A, Pulit, SL, et al. Fine mapping in the MHC region accounts for 18% additional genetic risk for celiac disease. Nat Genet 47 (2015), 577–578.
23. Castellanos-Rubio, A, Fernandez-Jimenez, N, Kratchmarov, R, et al. A long noncoding RNA associated with susceptibility to celiac disease. Science 352 (2016), 91–95.
24. Ivarsson, A, Persson, LA, Nyström, L, et al. Epidemic of coeliac disease in Swedish children. Acta Paediatr 89 (2000), 165–171.
25. Welander, A, Tjernberg, AR, Montgomery, SM, Ludvigsson, J, Ludvigsson, JF, Infectious disease and risk of later celiac disease in childhood. Pediatrics 125 (2010), e530–e536.
26. Aronsson, CA, Lee, HS, Liu, E, et al., for the TEDDY Study Group. Age at gluten introduction and risk of celiac disease. Pediatrics 135 (2015), 239–245.
27. Lionetti, E, Castellaneta, S, Francavilla, R, et al., for the SIGENP (Italian Society of Pediatric Gastroenterology, Hepatology, and Nutrition) Working Group on Weaning and CD Risk. Introduction of gluten, HLA status, and the risk of celiac disease in children. N Engl J Med 371 (2014), 1295–1303.
28. Vriezinga, SL, Auricchio, R, Bravi, E, et al. Randomized feeding intervention in infants at high risk for celiac disease. N Engl J Med 371 (2014), 1304–1315.
29. Liu, E, Lee, HS, Aronsson, CA, et al., for the TEDDY Study Group. Risk of pediatric celiac disease according to HLA haplotype and country. N Engl J Med 371 (2014), 42–49.
30. Andrén Aronsson, C, Lee, HS, Koletzko, S, et al., for the TEDDY Study Group. Effects of gluten intake on risk of celiac disease: a case-control study on a Swedish birth cohort. Clin Gastroenterol Hepatol 14 (2016), 403–409.
31. Crespo-Escobar, P, Mearin, ML, Hervás, D, et al. The role of gluten consumption at an early age in celiac disease development: a further analysis of the prospective PreventCD cohort study. Am J Clin Nutr 105 (2017), 890–896.
32. Szajewska, H, Shamir, R, Mearin, L, et al. Gluten introduction and the risk of coeliac disease: a position paper by the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 62 (2016), 507–513.
33. Pinto-Sánchez, MI, Verdu, EF, Liu, E, et al. Gluten introduction to infant feeding and risk of celiac disease: systematic review and meta-analysis. J Pediatr 168 (2016), 132–143.
34. Lebwohl, B, Green, PH, Murray, JA, Ludvigsson, JF, Season of birth in a nationwide cohort of coeliac disease patients. Arch Dis Child 98 (2013), 48–51.
35. Tanpowpong, P, Obuch, JC, Jiang, H, et al. Multicenter study on season of birth and celiac disease: evidence for a new theoretical model of pathogenesis. J Pediatr 162 (2013), 501–504.
36. Mårild, K, Stephansson, O, Montgomery, S, Murray, JA, Ludvigsson, JF, Pregnancy outcome and risk of celiac disease in offspring: a nationwide case-control study. Gastroenterology 142 (2012), 39–45.
37. Lionetti, E, Castellaneta, S, Francavilla, R, Pulvirenti, A, Catassi, C, for the SIGENP Working Group of Weaning and CD Risk. Mode of delivery and risk of celiac disease: risk of celiac disease and age at gluten introduction cohort study. J Pediatr 184 (2017), 81–86.
38. Canova, C, Zabeo, V, Pitter, G, et al. Association of maternal education, early infections, and antibiotic use with celiac disease: a population-based birth cohort study in northeastern Italy. Am J Epidemiol 180 (2014), 76–85.
39. Stene, LC, Honeyman, MC, Hoffenberg, EJ, et al. Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study. Am J Gastroenterol 101 (2006), 2333–2340.
40. Riddle, MS, Murray, JA, Cash, BD, Pimentel, M, Porter, CK, Pathogen-specific risk of celiac disease following bacterial causes of foodborne illness: a retrospective cohort study. Dig Dis Sci 58 (2013), 3242–3245.
41. Kemppainen, KM, Lynch, KF, Liu, E, et al., for the TEDDY Study Group. Factors that increase risk of celiac disease autoimmunity after a gastrointestinal infection in early life. Clin Gastroenterol Hepatol 15 (2017), 694–702.
42. Mårild, K, Kahrs, CR, Tapia, G, Stene, LC, Størdal, K, Infections and risk of celiac disease in childhood: a prospective nationwide cohort study. Am J Gastroenterol 110 (2015), 1475–1484.
43. Mårild, K, Ye, W, Lebwohl, B, et al. Antibiotic exposure and the development of coeliac disease: a nationwide case-control study. BMC Gastroenterol, 13, 2013, 109.
44. Lebwohl, B, Spechler, SJ, Wang, TC, Green, PH, Ludvigsson, JF, Use of proton pump inhibitors and subsequent risk of celiac disease. Dig Liver Dis 46 (2014), 36–40.
45. Størdal, K, Haugen, M, Brantsæter, AL, Lundin, KE, Stene, LC, Association between maternal iron supplementation during pregnancy and risk of celiac disease in children. Clin Gastroenterol Hepatol 12 (2014), 624–631.
46. Mårild, K, Ludvigsson, J, Sanz, Y, Ludvigsson, JF, Antibiotic exposure in pregnancy and risk of coeliac disease in offspring: a cohort study. BMC Gastroenterol, 14, 2014, 75.
47. Lebwohl, B, Blaser, MJ, Ludvigsson, JF, et al. Decreased risk of celiac disease in patients with Helicobacter pylori colonization. Am J Epidemiol 178 (2013), 1721–1730.
48. Bouziat, R, Hinterleitner, R, Brown, JJ, et al. Reovirus infection triggers inflammatory responses to dietary antigens and development of celiac disease. Science 356 (2017), 44–50.
49. Galipeau, HJ, McCarville, JL, Huebener, S, et al. Intestinal microbiota modulates gluten-induced immunopathology in humanized mice. Am J Pathol 185 (2015), 2969–2982.
50. Nistal, E, Caminero, A, Vivas, S, et al. Differences in faecal bacteria populations and faecal bacteria metabolism in healthy adults and celiac disease patients. Biochimie 94 (2012), 1724–1729.
51. Nadal, I, Donat, E, Ribes-Koninckx, C, Calabuig, M, Sanz, Y, Imbalance in the composition of the duodenal microbiota of children with coeliac disease. J Med Microbiol 56 (2007), 1669–1674.
52. Nistal, E, Caminero, A, Herrán, AR, et al. Study of duodenal bacterial communities by 16S rRNA gene analysis in adults with active celiac disease vs non-celiac disease controls. J Appl Microbiol 120 (2016), 1691–1700.
53. Nistal, E, Caminero, A, Herrán, AR, et al. Differences of small intestinal bacteria populations in adults and children with/without celiac disease: effect of age, gluten diet, and disease. Inflamm Bowel Dis 18 (2012), 649–656.
54. De Palma, G, Nadal, I, Collado, MC, Sanz, Y, Effects of a gluten-free diet on gut microbiota and immune function in healthy adult human subjects. Br J Nutr 102 (2009), 1154–1160.
55. Olivares, M, Neef, A, Castillejo, G, et al. The HLA-DQ2 genotype selects for early intestinal microbiota composition in infants at high risk of developing coeliac disease. Gut 64 (2015), 406–417.
56. Rubio-Tapia, A, Ludvigsson, JF, Brantner, TL, Murray, JA, Everhart, JE, The prevalence of celiac disease in the United States. Am J Gastroenterol 107 (2012), 1538–1544.
57. Choung, RS, Larson, SA, Khaleghi, S, et al. Prevalence and morbidity of undiagnosed celiac disease from a community-based study. Gastroenterology 152 (2017), 830–839.
58. Mustalahti, K, Catassi, C, Reunanen, A, et al. for the Coeliac EU Cluster, Project Epidemiology. The prevalence of celiac disease in Europe: results of a centralized, international mass screening project. Ann Med 42 (2010), 587–595.
59. Choung, RS, Ditah, IC, Nadeau, AM, et al. Trends and racial/ethnic disparities in gluten-sensitive problems in the United States: findings from the National Health and Nutrition Examination Surveys from 1988 to 2012. Am J Gastroenterol 110 (2015), 455–461.
60. Almeida, RC, Gandolfi, L, De Nazaré Klautau-Guimarães, M, et al. Does celiac disease occur in Afro-derived Brazilian populations?. Am J Hum Biol 24 (2012), 710–712.
61. Ramakrishna, BS, Makharia, GK, Chetri, K, et al. Prevalence of adult celiac disease in India: regional variations and associations. Am J Gastroenterol 111 (2016), 115–123.
62. Krigel, A, Turner, KO, Makharia, GK, Green, PH, Genta, RM, Lebwohl, B, Ethnic variations in duodenal villous atrophy consistent with celiac disease in the United States. Clin Gastroenterol Hepatol 14 (2016), 1105–1111.
63. Rubio-Tapia, A, Kyle, RA, Kaplan, EL, et al. Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology 137 (2009), 88–93.
64. Catassi, C, Kryszak, D, Bhatti, B, et al. Natural history of celiac disease autoimmunity in a USA cohort followed since 1974. Ann Med 42 (2010), 530–538.
65. Lohi, S, Mustalahti, K, Kaukinen, K, et al. Increasing prevalence of coeliac disease over time. Aliment Pharmacol Ther 26 (2007), 1217–1225.
66. Myléus, A, Ivarsson, A, Webb, C, et al. Celiac disease revealed in 3% of Swedish 12-year-olds born during an epidemic. J Pediatr Gastroenterol Nutr 49 (2009), 170–176.
67. Choung, RS, Unalp-Arida, A, Ruhl, CE, Brantner, TL, Everhart, JE, Murray, JA, Less hidden celiac disease but increased gluten avoidance without a diagnosis in the United States: findings from the National Health and Nutrition Examination surveys from 2009 to 2014. Mayo Clin Proc, 2016 published online Dec 5. DOI:10.1016/j.mayocp.2016.10.012.
68. Gasbarrini, G, Miele, L, Malandrino, N, et al. Celiac disease in the 21st century: issues of under- and over-diagnosis. Int J Immunopathol Pharmacol 22 (2009), 1–7.
69. Collin, P, Huhtala, H, Virta, L, Kekkonen, L, Reunala, T, Diagnosis of celiac disease in clinical practice: physician's alertness to the condition essential. J Clin Gastroenterol 41 (2007), 152–156.
70. Ludvigsson, JF, Leffler, DA, Bai, JC, et al. The Oslo definitions for coeliac disease and related terms. Gut 62 (2013), 43–52.
71. Downey, L, Houten, R, Murch, S, Longson, D, for the Guideline Development Group. Recognition, assessment, and management of coeliac disease: summary of updated NICE guidance. BMJ, 351, 2015, h4513.
72. Gray, AM, Papanicolas, IN, Impact of symptoms on quality of life before and after diagnosis of coeliac disease: results from a UK population survey. BMC Health Serv Res, 10, 2010, 105.
73. Rubio-Tapia, A, Hill, ID, Kelly, CP, Calderwood, AH, Murray, JA, for the American College of Gastroenterology. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol 108 (2013), 656–676.
74. Ludvigsson, JF, Bai, JC, Biagi, F, et al. for the BSG Coeliac Disease Guidelines Development Group, British Society of Gastroenterology. Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology. Gut 63 (2014), 1210–1228.
75. Hopper, AD, Hadjivassiliou, M, Hurlstone, DP, et al. What is the role of serologic testing in celiac disease? A prospective, biopsy-confirmed study with economic analysis. Clin Gastroenterol Hepatol 6 (2008), 314–320.
76. Leffler, DA, Schuppan, D, Update on serologic testing in celiac disease. Am J Gastroenterol 105 (2010), 2520–2524.
77. Lewis, NR, Scott, BB, Meta-analysis: deamidated gliadin peptide antibody and tissue transglutaminase antibody compared as screening tests for coeliac disease. Aliment Pharmacol Ther 31 (2010), 73–81.
78. Hoerter, NA, Shannahan, SE, Suarez, J, et al. Diagnostic yield of isolated deamidated gliadin peptide antibody elevation for celiac disease. Dig Dis Sci 62 (2017), 1272–1276.
79. Giersiepen, K, Lelgemann, M, Stuhldreher, N, et al., for the ESPGHAN Working Group on Coeliac Disease Diagnosis. Accuracy of diagnostic antibody tests for coeliac disease in children: summary of an evidence report. J Pediatr Gastroenterol Nutr 54 (2012), 229–241.
80. Leffler, D, Schuppan, D, Pallav, K, et al. Kinetics of the histological, serological and symptomatic responses to gluten challenge in adults with coeliac disease. Gut 62 (2013), 996–1004.
81. Raju, SA, Mooney, PD, Aziz, I, Kurien, M, Sanders, DS, Letter: gluten challenge in the era of noncoeliac gluten sensitivity—a change in clinical practice?. Aliment Pharmacol Ther, 43, 2016, 656.
82. Brocchi, E, Corazza, GR, Caletti, G, Treggiari, EA, Barbara, L, Gasbarrini, G, Endoscopic demonstration of loss of duodenal folds in the diagnosis of celiac disease. N Engl J Med 319 (1988), 741–744.
83. Brocchi, E, Tomassetti, P, Misitano, B, et al. Endoscopic markers in adult coeliac disease. Dig Liver Dis 34 (2002), 177–182.
84. Shah, VH, Rotterdam, H, Kotler, DP, Fasano, A, Green, PH, All that scallops is not celiac disease. Gastrointest Endosc 51 (2000), 717–720.
85. Biesiekierski, JR, Newnham, ED, Irving, PM, et al. Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial. Am J Gastroenterol 106 (2011), 508–514.
86. Husby, S, Koletzko, S, Korponay-Szabó, IR, et al. for the ESPGHAN Working Group on Coeliac Disease Diagnosis; ESPGHAN Gastroenterology Committee, European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. European Society For Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 54 (2012), 136–160.
87. Sugai, E, Hwang, HJ, Vázquez, H, et al. Should ESPGHAN guidelines for serologic diagnosis of celiac disease be used in adults? A prospective analysis in an adult patient cohort with high pretest probability. Am J Gastroenterol 110 (2015), 1504–1505.
88. Taavela, J, Koskinen, O, Huhtala, H, et al. Validation of morphometric analyses of small-intestinal biopsy readouts in celiac disease. PLoS One, 8, 2013, e76163.
89. Mooney, PD, Kurien, M, Evans, KE, et al. Clinical and immunologic features of ultra-short celiac disease. Gastroenterology 150 (2016), 1125–1134.
90. Stoven, SA, Choung, RS, Rubio-Tapia, A, et al. Analysis of biopsies from duodenal bulbs of all endoscopy patients increases detection of abnormalities but has a minimal effect on diagnosis of celiac disease. Clin Gastroenterol Hepatol 14 (2016), 1582–1588.
91. Latorre, M, Lagana, SM, Freedberg, DE, et al. Endoscopic biopsy technique in the diagnosis of celiac disease: one bite or two?. Gastrointest Endosc 81 (2015), 1228–1233.
92. Lebwohl, B, Kapel, RC, Neugut, AI, Green, PH, Genta, RM, Adherence to biopsy guidelines increases celiac disease diagnosis. Gastrointest Endosc 74 (2011), 103–109.
93. Sanders, DS, Hurlstone, DP, Stokes, RO, et al. Changing face of adult coeliac disease: experience of a single university hospital in South Yorkshire. Postgrad Med J 78 (2002), 31–33.
94. Lebwohl, B, Bhagat, G, Markoff, S, et al. Prior endoscopy in patients with newly diagnosed celiac disease: a missed opportunity?. Dig Dis Sci 58 (2013), 1293–1298.
95. Pallav, K, Kabbani, T, Tariq, S, Vanga, R, Kelly, CP, Leffler, DA, Clinical utility of celiac disease-associated HLA testing. Dig Dis Sci 59 (2014), 2199–2206.
96. Chang, MS, Rubin, M, Lewis, SK, Green, PH, Diagnosing celiac disease by video capsule endoscopy (VCE) when esophagogastroduodenoscopy (EGD) and biopsy is unable to provide a diagnosis: a case series. BMC Gastroenterol, 12, 2012, 90.
97. Murray, JA, Rubio-Tapia, A, Van Dyke, CT, et al. Mucosal atrophy in celiac disease: extent of involvement, correlation with clinical presentation, and response to treatment. Clin Gastroenterol Hepatol 6 (2008), 186–193.
98. Collin, P, Kaukinen, K, Vogelsang, H, et al. Antiendomysial and antihuman recombinant tissue transglutaminase antibodies in the diagnosis of coeliac disease: a biopsy-proven European multicentre study. Eur J Gastroenterol Hepatol 17 (2005), 85–91.
99. Salmi, TT, Collin, P, Korponay-Szabó, IR, et al. Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits. Gut 55 (2006), 1746–1753.
100. Volta, U, Caio, G, Boschetti, E, et al. Seronegative celiac disease: shedding light on an obscure clinical entity. Dig Liver Dis 48 (2016), 1018–1022.
101. Rostami, K, Kerckhaert, J, Tiemessen, R, et al. Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: disappointing in clinical practice. Am J Gastroenterol 94 (1999), 888–894.
102. Aziz, I, Peerally, MF, Barnes, JH, et al. The clinical and phenotypical assessment of seronegative villous atrophy; a prospective UK centre experience evaluating 200 adult cases over a 15-year period (2000–2015). Gut, 2016 published online Sept 7. DOI:10.1136/gutjnl-2016-312271.
103. DeGaetani, M, Tennyson, CA, Lebwohl, B, et al. Villous atrophy and negative celiac serology: a diagnostic and therapeutic dilemma. Am J Gastroenterol 108 (2013), 647–653.
104. Godfrey, JD, Brantner, TL, Brinjikji, W, et al. Morbidity and mortality among older individuals with undiagnosed celiac disease. Gastroenterology 139 (2010), 763–769.
105. Bakker, SF, Tushuizen, ME, von Blomberg, BM, Bontkes, HJ, Mulder, CJ, Simsek, S, Screening for coeliac disease in adult patients with type 1 diabetes mellitus: myths, facts and controversy. Diabetol Metab Syndr, 8, 2016, 51.
106. Mahmud, FH, De Melo, EN, Noordin, K, et al. The Celiac Disease and Diabetes-Dietary Intervention and Evaluation Trial (CD-DIET) protocol: a randomised controlled study to evaluate treatment of asymptomatic coeliac disease in type 1 diabetes. BMJ Open, 5, 2015, e008097.
107. Murray, JA, Watson, T, Clearman, B, Mitros, F, Effect of a gluten-free diet on gastrointestinal symptoms in celiac disease. Am J Clin Nutr 79 (2004), 669–673.
108. Lee, AR, Ng, DL, Zivin, J, Green, PH, Economic burden of a gluten-free diet. J Hum Nutr Diet 20 (2007), 423–430.
109. Shah, S, Akbari, M, Kelly, CP, et al. Celiac disease has higher treatment burden than common medical conditions. Gastroenterology, 142, 2012, S87.
110. England, CY, Nicholls, AM, Advice available on the Internet for people with coeliac disease: an evaluation of the quality of websites. J Hum Nutr Diet 17 (2004), 547–559.
111. Barratt, SM, Leeds, JS, Sanders, DS, Quality of life in Coeliac Disease is determined by perceived degree of difficulty adhering to a gluten-free diet, not the level of dietary adherence ultimately achieved. J Gastrointestin Liver Dis 20 (2011), 241–245.
112. Ludvigsson, JF, Agreus, L, Ciacci, C, et al. Transition from childhood to adulthood in coeliac disease: the Prague consensus report. Gut 65 (2016), 1242–1251.
113. Mangione, RA, Patel, PN, Shin, E, Fiebert, J, Determining the gluten content of nonprescription drugs: information for patients with celiac disease. J Am Pharm Assoc 51 (2011), 734–737.
114. Zingone, F, Abdul Sultan, A, Crooks, CJ, Tata, LJ, Ciacci, C, West, J, The risk of community-acquired pneumonia among 9803 patients with coeliac disease compared to the general population: a cohort study. Aliment Pharmacol Ther 44 (2016), 57–67.
115. Olmos, M, Antelo, M, Vazquez, H, Smecuol, E, Mauriño, E, Bai, JC, Systematic review and meta-analysis of observational studies on the prevalence of fractures in coeliac disease. Dig Liver Dis 40 (2008), 46–53.
116. Aziz, I, Evans, KE, Papageorgiou, V, Sanders, DS, Are patients with coeliac disease seeking alternative therapies to a gluten-free diet?. J Gastrointestin Liver Dis 20 (2011), 27–31.
117. McCarville, JL, Caminero, A, Verdu, EF, Pharmacological approaches in celiac disease. Curr Opin Pharmacol 25 (2015), 7–12.
118. Goel, G, King, T, Daveson, AJ, et al. Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies. Lancet Gastroenterol Hepatol, 2017 published online May 11. DOI:10.1016/S2468-1253(17)30110-3.
119. Leffler, DA, Kelly, CP, Green, PH, et al. Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: a randomized controlled trial. Gastroenterology 148 (2015), 1311–1319.
120. Murray, JA, Kelly, CP, Green, PH, et al., for the CeliAction Study Group of Investigators. No difference between latiglutenase and placebo in reducing villous atrophy or improving symptoms in patients with symptomatic celiac disease. Gastroenterology 152 (2017), 787–798.
121. Leffler, DA, Dennis, M, Hyett, B, Kelly, E, Schuppan, D, Kelly, CP, Etiologies and predictors of diagnosis in nonresponsive celiac disease. Clin Gastroenterol Hepatol 5 (2007), 445–450.
122. Rubio-Tapia, A, Barton, SH, Murray, JA, Celiac disease and persistent symptoms. Clin Gastroenterol Hepatol 9 (2011), 13–17.
123. Lebwohl, B, Murray, JA, Rubio-Tapia, A, Green, PH, Ludvigsson, JF, Predictors of persistent villous atrophy in coeliac disease: a population-based study. Aliment Pharmacol Ther 39 (2014), 488–495.
124. Leonard, MM, Weir, DC, DeGroote, M, et al. Value of IgA tTG in predicting mucosal recovery in children with celiac disease on a gluten-free diet. J Pediatr Gastroenterol Nutr 64 (2017), 286–291.
125. Lebwohl, B, Granath, F, Ekbom, A, et al. Mucosal healing and risk of lymphoproliferative malignancy in celiac disease. Ann Intern Med 159 (2013), 169–175.
126. Lebwohl, B, Michaëlsson, K, Green, PH, Ludvigsson, JF, Persistent mucosal damage and risk of fracture in celiac disease. J Clin Endocrinol Metab 99 (2014), 609–616.
127. Sharkey, LM, Corbett, G, Currie, E, Lee, J, Sweeney, N, Woodward, JM, Optimising delivery of care in coeliac disease—comparison of the benefits of repeat biopsy and serological follow-up. Aliment Pharmacol Ther 38 (2013), 1278–1291.
128. Hollon, JR, Cureton, PA, Martin, ML, Puppa, EL, Fasano, A, Trace gluten contamination may play a role in mucosal and clinical recovery in a subgroup of diet-adherent non-responsive celiac disease patients. BMC Gastroenterol, 13, 2013, 40.
129. Cellier, C, et al., for the French Coeliac Disease Study Group. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. Lancet 356 (2000), 203–208.
130. Rubio-Tapia, A, Kelly, DG, Lahr, BD, Dogan, A, Wu, TT, Murray, JA, Clinical staging and survival in refractory celiac disease: a single center experience. Gastroenterology 136 (2009), 99–107.
131. Rubio-Tapia, A, Malamut, G, Verbeek, WH, et al. Creation of a model to predict survival in patients with refractory coeliac disease using a multinational registry. Aliment Pharmacol Ther 44 (2016), 704–714.
132. Elfstrom, P, Granath, F, Ekström Smedby, K, et al. Risk of lymphoproliferative malignancy in relation to small intestinal histopathology among patients with celiac disease. J Natl Cancer Inst 103 (2011), 436–444.
133. Ilus, T, Kaukinen, K, Virta, LJ, Pukkala, E, Collin, P, Incidence of malignancies in diagnosed celiac patients: a population-based estimate. Am J Gastroenterol 109 (2014), 1471–1477.
134. Elfström, P, Granath, F, Ye, W, Ludvigsson, JF, Low risk of gastrointestinal cancer among patients with celiac disease, inflammation, or latent celiac disease. Clin Gastroenterol Hepatol 10 (2012), 30–36.
135. Lebwohl, B, Stavsky, E, Neugut, AI, Green, PH, Risk of colorectal adenomas in patients with coeliac disease. Aliment Pharmacol Ther 32 (2010), 1037–1043.
136. Green, PH, Fleischauer, AT, Bhagat, G, Goyal, R, Jabri, B, Neugut, AI, Risk of malignancy in patients with celiac disease. Am J Med 115 (2003), 191–195.
137. West, J, Logan, RF, Smith, CJ, Hubbard, RB, Card, TR, Malignancy and mortality in people with coeliac disease: population based cohort study. BMJ 329 (2004), 716–719.
138. Tio, M, Cox, MR, Eslick, GD, Meta-analysis: coeliac disease and the risk of all-cause mortality, any malignancy and lymphoid malignancy. Aliment Pharmacol Ther 35 (2012), 540–551.
139. Logan, RF, Rifkind, EA, Turner, ID, Ferguson, A, Mortality in celiac disease. Gastroenterology 97 (1989), 265–271.
140. Ludvigsson, JF, Montgomery, SM, Ekbom, A, Brandt, L, Granath, F, Small-intestinal histopathology and mortality risk in celiac disease. JAMA 302 (2009), 1171–1178.
141. Johnston, SD, Watson, RG, McMillan, SA, Sloan, J, Love, AH, Coeliac disease detected by screening is not silent—simply unrecognized. QJM 91 (1998), 853–860.
142. Lohi, S, Mäki, M, Rissanen, H, Knekt, P, Reunanen, A, Kaukinen, K, Prognosis of unrecognized coeliac disease as regards mortality: a population-based cohort study. Ann Med 41 (2009), 508–515.
143. Moreno, ML, Rodríguez-Herrera, A, Sousa, C, Comino, I, Biomarkers to monitor gluten-free diet compliance in celiac patients. Nutrients, 9, 2017.
144. Comino, I, Fernández-Bañares, F, Esteve, M, et al. Fecal gluten peptides reveal limitations of serological tests and food questionnaires for monitoring gluten-free diet in celiac disease patients. Am J Gastroenterol 111 (2016), 1456–1465.